263 related articles for article (PubMed ID: 12218231)
1. The antibacterial activity of topical retinoids: the case of retinaldehyde.
Pechère M; Germanier L; Siegenthaler G; Pechère JC; Saurat JH
Dermatology; 2002; 205(2):153-8. PubMed ID: 12218231
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of retinaldehyde against Propionibacterium acnes.
Pechère M; Pechère JC; Siegenthaler G; Germanier L; Saurat JH
Dermatology; 1999; 199 Suppl 1():29-31. PubMed ID: 10473957
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of topical retinaldehyde and retinol by mouse skin in vivo: predominant formation of retinyl esters and identification of 14-hydroxy-4, 14-retro-retinol.
Sass JO; Didierjean L; Carraux P; Plum C; Nau H; Saurat JH
Exp Dermatol; 1996 Oct; 5(5):267-71. PubMed ID: 8981025
[TBL] [Abstract][Full Text] [Related]
4. Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions.
Fluhr JW; Vienne MP; Lauze C; Dupuy P; Gehring W; Gloor M
Dermatology; 1999; 199 Suppl 1():57-60. PubMed ID: 10473963
[TBL] [Abstract][Full Text] [Related]
5. Plasma retinoids after topical use of retinaldehyde on human skin.
Sass JO; Masgrau E; Piletta PA; Nau H; Saurat JH
Skin Pharmacol; 1996; 9(5):322-6. PubMed ID: 8990507
[TBL] [Abstract][Full Text] [Related]
6. Biological activities of topical retinaldehyde.
Didierjean L; Tran C; Sorg O; Saurat JH
Dermatology; 1999; 199 Suppl 1():19-24. PubMed ID: 10473955
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of RALGA, a mixture of retinaldehyde and glycolic acid.
Tran C; Kasraee B; Grand D; Carraux P; Didierjean L; Sorg O; Saurat JH
Dermatology; 2005; 210 Suppl 1():6-13. PubMed ID: 15724102
[TBL] [Abstract][Full Text] [Related]
8. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
[TBL] [Abstract][Full Text] [Related]
9. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2002 Feb; 55(1):1-21. PubMed ID: 11977919
[TBL] [Abstract][Full Text] [Related]
10. Spectral and mass characterization of kinetic conversion from retinoids to retinoic acid in an in vitro 3-D human skin equivalent model.
Kim JE; Lee DY; Choi J; Hong YD; Nam J; Park WS; Shim SM
Eur J Pharm Sci; 2024 Jul; 198():106784. PubMed ID: 38705422
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
Chamberland S; Blais J; Hoang M; Dinh C; Cotter D; Bond E; Gannon C; Park C; Malouin F; Dudley MN
Antimicrob Agents Chemother; 2001 May; 45(5):1422-30. PubMed ID: 11302805
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the in vitro antibacterial effects of statins].
Coban AY; Tekeli HO; Güney AK; Durupinar B
Mikrobiyol Bul; 2010 Jan; 44(1):161-3. PubMed ID: 20455414
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of antibacterial activity of sertralin].
Coban AY; Tanriverdi Cayci Y; Keleş Uludağ S; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):651-6. PubMed ID: 20084919
[TBL] [Abstract][Full Text] [Related]
14. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
Sader HS; Watters AA; Fritsche TR; Jones RN
BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antibacterial activity of 5-halogenomethylsulfonyl- benzimidazole and benzotriazole derivatives.
Ochal Z; Bretner M; Wolinowska R; Tyski S
Med Chem; 2013 Dec; 9(8):1129-36. PubMed ID: 23339322
[TBL] [Abstract][Full Text] [Related]
18. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
[TBL] [Abstract][Full Text] [Related]
19. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antibacterial activities of broad spectrum quinolones against clinical bacterial isolates].
Ishii Y; Ohno A; Yamaguchi K
Jpn J Antibiot; 1994 Jan; 47(1):22-8. PubMed ID: 8114270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
